Objective: To reanalyze data from two previous studies to provide stronger evidence of benefit for early use of single-dose intravenous bolus salbutamol in children with acute severe exacerbations ...

DelveInsight's "CABLIVI Market Size, Forecast, and Market Insight Report" highlights the details around CABLIVI, a von ...

The incident occurred recently at Lifecare Hospital in Musaffah, where Dr Aboobacker Sidhique, a Specialist in Emergency ...

Developed by Sanofi, CABLIVI is the first FDA-approved nanobody therapy for this condition. Increasing awareness, improved diagnostic rates, and rising demand for targeted therapies in hematology ...

A new trial refutes this finding. The subjects, 636 patients who underwent successful coronary stenting, were randomized to an initial intravenous bolus and a 6-month oral regimen of either ...

So overall, I think very excited about the intravenous LEQEMBI approval that ... But importantly, there is going to be this bolus of patients who are going to be completing their 18-month therapy ...

The National Registry of Emergency Medical Technicians is America’s EMS certification organization – here’s how it works ...

Since their first use for treating rheumatoid arthritis (RA) in the late 1940s, glucocorticoids (GCs) have been representing a substantial part of the therapeutic arsenal for RA. However, even if GCs ...